IP Library › Granted Patent US 10,925,263
Granted Patent B2
US 10,925,263 · App. 16/708,655 · Granted Feb 23, 2021

Multiplexed genome editing

Inventors: George M. Church (Brookline, MA); Luhan Yang (Somerville, MA); Marc Guell (Barcelona, ES)
Assignee: President and Fellows of Harvard College
A01K67/0275A01K67/0273A01K67/0276C12N7/00C12N9/22C12N15/11C12N15/1132C12N15/63C12N15/85C12N15/8509C12N15/907A01K2207/05A01K2207/10A01K2227/108A01K2267/025C12N2310/20C12N2740/10062C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,925,263
App. No.
16/708,655
Granted
Feb 23, 2021
Kind
B2
Abstract

A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.

Claims (6)

1. An isolated porcine organ comprising a plurality of genetically engineered porcine cells, wherein each genetically engineered porcine cell of said plurality is characterized in that at least 97% of the porcine endogenous retrovirus (PERV) pol genes comprise a genetically engineered genomic indel.

2. The organ of claim 1 , wherein 100% of the PERV pol genes comprise a genetically engineered genomic indel.

3. The organ of claim 1 , wherein each genetically engineered porcine cell exhibits at least a 1000-fold reduction in PERV transmission as evidenced by co-culturing a human cell with the genetically engineered porcine cell as compared to co-culturing a human cell with a wild-type porcine cell.

4. The organ of claim 3 , wherein the human cell is HEK293.

5. The organ of claim 1 , wherein the genetically engineered genomic indel is observed by sequencing.

6. The organ of claim 1 , wherein the individual genetically engineered porcine cell contains intact PERV gag and/or env genes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2020
From: CHURCH, GEORGE M.; GUELL, MARC; YANG, LUHAN
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 051937/0081 →
Continuity (4)
Division 16531351 · Aug 5, 2019
Continuation 15766551
Provisional Application 62239239 · Oct 8, 2015
Related Publication 20200170229A1 · Jun 4, 2020
Cited By (2)
US 12,630,838 US 12,637,690